NVX 428Alternative Names: NVX-428
Latest Information Update: 27 May 2016
At a glance
- Originator NuvOx Pharma
- Class Fluorocarbons
- Mechanism of Action Oxygen carriers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Brain injuries
Most Recent Events
- 07 Oct 2014 Preclinical trials in Brain injuries in USA (IV) before October 2014